Christopher J. Schultz, MD, FACR, FASTRO

Chair and Bernard & Miriam Peck Family Professor of Radiation Oncology

Locations

Radiation Oncology

Contact Information

(414) 805-4472

Education

1985, Medical College of Wisconsin, MD

Biography

Training

Residency Radiation Oncology, University of Wisconsin Hospitals and Clinics, Madison, WI (1989-1990)

Residency Radiation Oncology, Presbyterian Hospital, New York, NY (1986-1988)

Internship Children's Mercy Hospital, Kansas City, MO (1985-1986)

Certifications

Recertification, Radiation Oncology, American Board of Radiology (2000)

Board Certification, Radiation Oncology, American Board of Radiology (1990)

Patient Care Emphases

Head and neck cancer
Hodgkin's Disease
Low dose rate irradiation
Gamma Knife stereotactic radiosurgery
Lymphoma
Brain tumors

View Provider Profile

Incorporating uncertainty bounds in daily deformable dose accumulation for adaptive radiation therapy of head-and-neck cancer.

(García-Alvarez JA, Zhong H, Schultz CJ, Li XA, Kainz K.) Med Phys. 2023 Apr;50(4):2474-2487 PMID: 36346034 SCOPUS ID: 2-s2.0-85142299603 11/09/2022
Development of a multi-layer quality assurance program to evaluate the uncertainty of deformable dose accumulation in adaptive radiotherapy.

(Zhong H, Garcia-Alvarez JA, Kainz K, Tai A, Ahunbay E, Erickson B, Schultz CJ, Li XA.) Med Phys. 2023 Mar;50(3):1766-1778 PMID: 36434751 PMCID: PMC10033340 SCOPUS ID: 2-s2.0-85144053188 11/27/2022
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States

(Raldow AC, Siker ML, Bonner JA, Chen Y, Liu FF, Metz JM, Movsas B, Potters L, Schultz CJ, Wilson E, Wang X, Romero T, Steinberg ML, Jagsi R.) Advances in Radiation Oncology. 1 September 2023;8(5) SCOPUS ID: 2-s2.0-85153065179 09/01/2023
Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology

(Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA.) Advances in Radiation Oncology. 1 July 2023;8(4) SCOPUS ID: 2-s2.0-85153041702 07/01/2023
Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma.

(Amidon RF, Santos-Pinheiro F, Straza M, Prah MA, Mueller WM, Krucoff MO, Connelly JM, Kleefisch CJ, Coss DJ, Cochran EJ, Bovi JA, Schultz CJ, Schmainda KM.) Front Oncol. 2022;12:1066191 PMID: 36561526 PMCID: PMC9763264 SCOPUS ID: 2-s2.0-85144231369 12/24/2022
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.

(Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD.) CA Cancer J Clin. 2022 Jan;72(1):34-56 PMID: 34792808 PMCID: PMC8985054 SCOPUS ID: 2-s2.0-85119184109 11/19/2021
Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry.

(de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium.) Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):867-875 PMID: 34265394 PMCID: PMC9764331 SCOPUS ID: 2-s2.0-85113219681 07/16/2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.

(Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT.) J Geriatr Oncol. 2021 Jul;12(6):937-944 PMID: 33814339 PMCID: PMC8829803 SCOPUS ID: 2-s2.0-85103725742 04/06/2021
Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.

(Awan MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, Nguyen-Tan PF, Rosenthal DI, Schultz C, Huth BJ, Thorstad WL, Frank SJ, Kim H, Foote RL, Lango MN, Shenouda G, Suntharalingam M, Harris J, Zhang Q, Le QT, Yao M, NRG Oncology Group.) Oral Oncol. 2021 May;116:105241 PMID: 33640577 PMCID: PMC8144062 SCOPUS ID: 2-s2.0-85101423773 03/01/2021
Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy.

(Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA.) Pract Radiat Oncol. 2021;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021
A closer look at 30 day hospital readmissions after head and neck cancer surgery

(Puccia R, Ramamurthi A, Grond SE, McCormick C, Ng A, Stadler M, Massey B, Campbell B, Shukla M, Awan M, Schultz C, Wong S, Shreenivas A, Zenga J.) American Journal of Otolaryngology - Head and Neck Medicine and Surgery. 1 September 2021;42(5) SCOPUS ID: 2-s2.0-85108366965 09/01/2021
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.

(Vassilakopoulou M, Won M, Curran WJ, Souhami L, Prados MD, Langer CJ, Rimm DL, Hanna JA, Neumeister VM, Melian E, Diaz AZ, Atkins JN, Komarnicky LT, Schultz CJ, Howard SP, Zhang P, Dicker AP, Knisely JPS.) Oncology. 2021;99(9):580-588 PMID: 33957633 PMCID: PMC8491475 SCOPUS ID: 2-s2.0-85107468485 05/07/2021